【微创医疗：心脉医疗预计净利润增幅达9.86%】金十数据1月20日讯，微创医疗(00853.HK)公告，预计旗下上海微创心脉医疗科技股份有限公司截至2024年12月31日止年度实现营业收入约11.88亿元至13.06亿元，较2023年度增长0.02%至10.01%；归属于心脉医疗科技所有者的净利润预计为4.92亿元至5.41亿元，同比增长0.01%至9.86%。心脉医疗科技的创新产品表现强劲，但市场环境变化导致全年销售增速和利润受到一定影响。报告期内，心脉医疗的海外销售收入超过1.5亿元，海外收入占比提升。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.